血管壁细胞在动脉粥样硬化中的作用研究进展
DOI:
作者:
作者单位:

(海军军医大学附属长海医院心内科,上海市200433)

作者简介:

努尔柯孜·阿卜杜合力力,硕士研究生,研究方向为冠状动脉粥样硬化性心脏病,E-mail:3445775378@qq.com。

通讯作者:

基金项目:

国家自然科学基金项目(81760076、82070419)


Research progress of vascular wall cells in atherosclerosis
Author:
Affiliation:

Department of Cardiology, Changhai Hospital, Naval Military Medical University, Shanghai 200433, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    动脉粥样硬化(As)是动脉壁慢性炎症性病变,血管壁细胞在As的发生、发展过程中发挥重要的作用。血管内皮细胞(VEC)作为血管平滑肌细胞(VSMC)和血管腔之间的半透性屏障,其损伤是As的初步阶段。VSMC通过表型转化产生斑块中的许多细胞表型,包括巨噬细胞样细胞、泡沫细胞、间充质干细胞样细胞等,进一步参与As的发生。成纤维细胞是血管外膜的主要成分,病理状态下成纤维细胞转化为肌成纤维细胞参与As的发生。本文综述了血管壁细胞参与As的机制及其潜在的治疗靶点,为As治疗提供新的思路。

    Abstract:

    Atherosclerosis (As) is a chronic inflammatory arterial wall injury process, and vessel wall cells play an important role in the occurrence and development of As. Vascular endothelial cell (VEC) act as a semi-permeable barrier between vascular smooth muscle cell (VSMC) and vascular lumen, and its injury is the initial stage of As. In addition, Through phenotypic transformation, VSMC could transform into many cell phenotype of the plaques, including macrophage, foam cell, mesenchymal stem cell and so on, and these cells further involved in the occurrence of As. Fibroblast is the main component of vascular adventitia,in pathological conditions, fibroblast differentiate into myofibroblast and participate in the occurrence of As. In this article, we will review the involvement of vascular wall cells in the mechanism of As and its potential therapeutic targets for the treatment of As, which provide new therapeutic ideas for As.

    参考文献
    相似文献
    引证文献
引用本文

努尔柯孜·阿卜杜合力力,张莎,吴弘.血管壁细胞在动脉粥样硬化中的作用研究进展[J].中国动脉硬化杂志,2025,33(1):85~92.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2023-10-18
  • 最后修改日期:2024-03-31
  • 录用日期:
  • 在线发布日期: 2025-01-26